Evidence map›Paper›PMID 38108809›Full record

ArticleeLife2023

Atlas of

Benjamin Liffner, Ana Karla Cepeda Diaz, James Blauwkamp, David Anaguano, Sonja Frolich, Vasant Muralidharan, Danny W Wilson, Jeffrey D Dvorin, Sabrina Absalon

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 64 citations in OpenAlex.

  1. Life science alliance · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Benjamin Liffner *Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States.ORCID 0000-0002-1573-6139
Ana Karla Cepeda Diaz *Biological and Biomedical Sciences, Harvard Medical School, Boston, United States.ORCID 0000-0002-2033-461X
James BlauwkampDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States.ORCID 0000-0002-7639-2800
David AnaguanoCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, United States.
Sonja FrolichResearch Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide, Australia.ORCID 0000-0002-8673-3437
Vasant MuralidharanCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, United States.ORCID 0000-0001-6367-6284
Danny W WilsonResearch Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide, Australia.ORCID 0000-0002-5073-1405
Jeffrey D DvorinDivision of Infectious Diseases, Boston Children's Hospital, Boston, United States.ORCID 0000-0002-5883-7271
Sabrina AbsalonDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States.ORCID 0000-0003-2468-8156
Indiana University School of MedicineBoston Children's Hospital · USUniversity of Georgia · USBurnet Institute · AUThe University of Adelaide · AU

Funding

Molecular mechanisms of schizogony in malaria parasitesR01AI145941 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI DVORIN, JEFFREY D · 2019 to 2023
$3.1M
UC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5M
Characterizing the Plasmodium falciparum Subpellicular NetworkF31AI172110 · NIAID · HARVARD MEDICAL SCHOOL · PI CEPEDA DIAZ, ANA KARLA · 2022 to 2023
$67k
NIAID NIH HHS F31 AI172110NIAID NIH HHS R01 AI145941NIAID NIH HHS R25 AI147376NIH HHS F31 AI172110NIH HHS R01 AI145941
6 · The paper itself

Abstract

Apicomplexan parasites exhibit tremendous diversity in much of their fundamental cell biology, but study of these organisms using light microscopy is often hindered by their small size. Ultrastructural expansion microscopy (U-ExM) is a microscopy preparation method that physically expands the sample by ~4.5×. Here, we apply U-ExM to the human malaria parasite

Indexed as

ApicoplastsAscomycotaMalaria, FalciparumHumansMicroscopyPlaque, AmyloidPlasmodium falciparumcytokinesisexpansion microscopyinfectious diseasemalariamicrobiologyMTOCP. falciparumPlasmodium

Identifiers

PMID38108809
PMCPMC10727503
OpenAlexW4377692971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.